Home » Topics » BioWorld Science

BioWorld Science
RSS

Uropontin and MAbs with potential in osteoporosis available for licensing

Nov. 26, 1996

Vaccine against H. influenzae offered for licensing

Nov. 26, 1996

Purified or recombinant proteins for HIV infection available for licensing

Nov. 26, 1996

Purified or recombinant protein for HIV infection and cancer offered for licensing

Nov. 26, 1996

Cationic antimicrobial peptides available for licensing

Nov. 26, 1996

New treatment for S. pneumoniae infection available for licensing

Nov. 26, 1996

Children's Hospital of Philadelphia offers treatment of H. influenzae for licensing

Nov. 26, 1996

Worldwide rights offered for protein inducing oligodendroglia mitosis

Nov. 26, 1996

Tularik receives patent coverage relating to drug discovery efforts

Nov. 26, 1996

Cambridge NeuroScience/Allergan ophthalmic disease collaboration

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...